<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02400671</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000916</org_study_id>
    <nct_id>NCT02400671</nct_id>
  </id_info>
  <brief_title>Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ART</brief_title>
  <acronym>Mobile WAChx</acronym>
  <official_title>Evaluation of Mhealth Strategies to Optimize Adherence and Efficacy of PMTCT/ART</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Nairobi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kenyatta National Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are conducting a 3-arm randomized trial comparing the effects of
      unidirectional SMS (ie: &quot;push&quot; messaging to participant) vs. bidirectional SMS dialogue
      between participant and provider vs. control (no SMS) among HIV-infected Kenyan mothers in
      Kenyan PMTCT-ART for outcomes of ART adherence and retention in care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will compare trial arms for impact on maternal retention, adherence,
      virologic failure and resistance and infant HIV or HIV-free survival.

      The investigators will determine correlates of maternal loss to follow-up and virologic
      failure and correlates of infant HIV in the overall study and stratified by trial arm. In the
      bidirectional SMS arm, the investigators will determine the rate of SMS interactivity, impact
      of critical time-points on messaging, and characteristics of high and low 'interactors'.

      The investigators will determine cost-effectiveness of unidirectional and bidirectional SMS
      interventions. These data will contribute a potential scale-able strategy to improve
      PMTCT-ART as programs aspire to 'virtual elimination' of infant HIV.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participants retained in HIV care programs</measure>
    <time_frame>2 years postpartum</time_frame>
    <description>The investigators will compare the trial arms for number of participants retained in HIV care programs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence to ART by self report and pharmacy data</measure>
    <time_frame>2 years postpartum</time_frame>
    <description>The investigators will compare the trial arms for number of participants adhering to ART measured by the number of doses taken over the number expected. This will be measured with previously validated self report scales and pharmacy refill data.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HIV viral suppression</measure>
    <time_frame>2 years</time_frame>
    <description>The investigators will compare trial arms for HIV viral suppression as measured by maternal blood levels of HIV RNA at 6 weeks, 6, 12, 18 and 24 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant HIV infection</measure>
    <time_frame>6 week, 6, 12, 18 and 24 months</time_frame>
    <description>The investigators will obtain infant testing data from the clinic system throughout follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant HIV-free survival</measure>
    <time_frame>6 weeks, 6 months and 2 years</time_frame>
    <description>The investigators will compare the trial arms for infant mortality and infant HIV infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal perceptions of intervention and care received Questionnaire</measure>
    <time_frame>At 2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">825</enrollment>
  <condition>mHealth</condition>
  <condition>PMTCT</condition>
  <condition>Adherence, Medication</condition>
  <condition>SMS</condition>
  <condition>Maternal Health</condition>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>Two-way SMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive weekly push SMS messaging with a questions and have the ability to text back to the study nurse</description>
  </arm_group>
  <arm_group>
    <arm_group_label>One-Way SMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive weekly push SMS messaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS messaging</intervention_name>
    <arm_group_label>Two-way SMS</arm_group_label>
    <arm_group_label>One-Way SMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant, HIV-infected, access to a mobile phone, remaining in study area for two
             years

        Exclusion Criteria:

          -  enrolled in another research study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grace John-Stewart</last_name>
    <role>Principal Investigator</role>
    <affiliation>UW</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ahero District Hospital</name>
      <address>
        <city>Ahero</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bondo District Hospital</name>
      <address>
        <city>Bondo</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mathare City Council Clinic</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riruta Health Centre</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rachuonyo sub-County Hospital</name>
      <address>
        <city>Rachuonyo</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siaya County Referral Hospital</name>
      <address>
        <city>Siaya</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <reference>
    <citation>Drake AL, Unger JA, Ronen K, Matemo D, Perrier T, DeRenzi B, Richardson BA, Kinuthia J, John-Stewart G. Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial. Contemp Clin Trials. 2017 Jun;57:44-50. doi: 10.1016/j.cct.2017.03.007. Epub 2017 Mar 14.</citation>
    <PMID>28315480</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2015</study_first_submitted>
  <study_first_submitted_qc>March 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2015</study_first_posted>
  <last_update_submitted>May 25, 2017</last_update_submitted>
  <last_update_submitted_qc>May 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Grace John-Stewart</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

